510(k) Report

510(k) · Decided

Decided

Lifestent NT35 Biliary Stent System

K042985510(k) SpecialDecided Dec 23, 200455-day reviewClass II21 CFR 876.5010

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Edwards Lifesciences, LLC · FGE Stents, Drains And Dilators For The Biliary Ducts

Cleared on Dec 23, 2004 as substantially equivalent to K024303 (Edwards Lifesciences, LLC, 2003) after a 55-day review. Its family tree reaches back 4 generations to 2001. 3 later devices descend from it.

Decided
Dec 23, 2004
Review
55 days
Class
Class II
Product code
FGE
Recalls
None
Predicates
1

Its longest line of descent runs back 4 generations to K010445 (2001). 7 ancestors in all, the oldest K971010 (1997). 3 later devices descend from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2000: 1 other ancestor2001: 1 other ancestor1997: 1 other ancestor2005: 1 descendant cleared2006: 1 descendant cleared2013: 1 descendant clearedK010445 · Precise Nitinol Stent Transhepatic Billary System · Cordis Corp. · 2001K012993 · Modification to Precise Nitinol Stent Transhepatic Biliary System · Cordis Corp. · 2001 · recalledK021898 · Smart Control Nitinol Stent Transhepatic Biliary System · Cordis Corp. · 2002 · recalledK024303 · Edwards Lifesciences Lifestent NT18 Self-Expanding Biliary Stent and Delivery System · Edwards Lifesciences, LLC · 20031995200020052010201520202025
  1. Root · 4 generations backK010445 Precise Nitinol Stent Transhepatic Billary SystemCordis Corp. · 2001
  2. 3 generations backK012993 Modification to Precise Nitinol Stent Transhepatic Biliary SystemCordis Corp. · 2001 · Recalled
  3. 2 generations backK021898 Smart Control Nitinol Stent Transhepatic Biliary SystemCordis Corp. · 2002 · Recalled
  4. 1 generation backK024303 Edwards Lifesciences Lifestent NT18 Self-Expanding Biliary Stent and…Edwards Lifesciences, LLC · 2003
  5. This deviceK042985 Lifestent NT35 Biliary Stent SystemEdwards Lifesciences, LLC · 2004
  6. Descendant · cites it directly · 2 of its ownK053404 Lifestent Flexstart Biliary Stent SystemEdwards Lifesciences, LLC · 2005 · Recalled
  7. Descendant · 2 generations on · 1 of its ownK060487 Lifestent Flexstar XL Biliary Stent SystemEdwards Lifesciences, LLC · 2006
  8. Descendant · 2 generations on · 0 of its ownK130792 Lifestent Biliary Stent System, Lifestent XL Biliary Stent SystemC.R. Bard, Inc. · 2013

Most influential descendants

Showing 3 of 3 · See all
  • K053404Lifestent Flexstart Biliary Stent SystemEdwards Lifesciences, LLC · 2005 · cites it directly2descendants
  • K060487Lifestent Flexstar XL Biliary Stent SystemEdwards Lifesciences, LLC · 2006 · 2 generations on1descendant
  • K130792Lifestent Biliary Stent System, Lifestent XL Biliary Stent SystemC.R. Bard, Inc. · 2013 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K010445Precise Nitinol Stent Transhepatic Billary SystemCordis Corp.2001—
−3K012993Modification to Precise Nitinol Stent Transhepatic Biliary SystemCordis Corp.20011
−2K021898Smart Control Nitinol Stent Transhepatic Biliary SystemCordis Corp.20021
−1K024303Edwards Lifesciences Lifestent NT18 Self-Expanding Biliary Stent and Delivery…Edwards Lifesciences, LLC2003—
0 (this device)K042985Lifestent NT35 Biliary Stent SystemEdwards Lifesciences, LLC2004—
+1K053404Lifestent Flexstart Biliary Stent SystemEdwards Lifesciences, LLC2005103
+2K060487Lifestent Flexstar XL Biliary Stent SystemEdwards Lifesciences, LLC2006—
+2K130792Lifestent Biliary Stent System, Lifestent XL Biliary Stent SystemC.R. Bard, Inc.2013—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199710
200010
200110

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200510
200610
201310
FIG. 1 — Lineage of K042985, 2001–2013Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FGE? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FGE device

  1. #1 K240464 WallFlex Biliary RX Stent System; Epic Biliary…score 14.5 · 13 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K024303Edwards Lifesciences Lifestent NT18 Self-Expanding Biliary Stent and Delivery System
Summary page 1
…mon Name: Biliary Stent 6. Device Classification Name: Biliary Catheter (18 FGE), Class 11 7. Predicate Devices: LifeStent NT18 Self-Expanding Biliary Stent System (K024303) Edwards Lifesciences Special 510(k) for the LifeStent NT35 Biliary Stent System…
Edwards Lifesciences, LLC2003—

Also cleared against K024303: 1 other device →

What descends from it? (3)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K053404Lifestent Flexstart Biliary Stent SystemEdwards Lifesciences, LLC20052

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 3 years and passes through 2 companies; a new generation was cleared every 11 months on median.
  • 2 of the 7 ancestors have a recall of any class.
  • Of its descendants, K053404 (Edwards Lifesciences, LLC, 2005) has gone furthest, with 2 descendants of its own.
  • 1 other device also cites its predicate K024303.

How does its category compare?

All FGE devices

FGE Stents, Drains And Dilators For The Biliary Ducts: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · FGE

7in 2025

2007: 42008: 112009: 72010: 92011: 92012: 82013: 52014: 82015: 82016: 42017: 92018: 72019: 22020: 42021: 12022: 62023: 62024: 62025: 72026 (partial year): 8
2007high 11 (2008) · low 1 (2021)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FGE

257in 2025

2007: 316 days median2008: 214 days median2009: 160 days median2010: 81 days median2011: 114 days median2012: 96 days median2013: 161 days median2014: 156 days median2015: 79 days median2016: 49 days median2017: 59 days median2018: 215 days median2020: 121 days median2022: 101 days median2023: 199 days median2024: 188 days median2025: 257 days median2026 (partial year): 153 days median
2007high 316 (2007) · low 49 (2016)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FGE

1in 2024

2007: 542008: 932009: 182010: 322011: 22012: 42013: 32017: 12018: 432019: 132020: 12021: 272022: 212023: 192024: 12026 (partial year): 11
2007high 93 (2008) · low 0 (2014)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · FGE

1,923in 2025

2007: 1,0062008: 1,4652009: 1,6552010: 1,4342011: 1,3212012: 1,1832013: 1,0602014: 1,2702015: 1,5432016: 1,4532017: 1,5152018: 1,6812019: 1,8962020: 2,1822021: 2,2972022: 1,7492023: 1,6152024: 1,9482025: 1,923
2007high 2,297 (2021) · low 1,006 (2007)2025

MAUDE reports naming product code FGE, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20074316541,006
200811214931,465
20097160181,655
2010981321,434
2011911421,321
201289641,183
2013516131,060
2014815601,270
201587901,543
201644901,453
201795911,515
20187215431,681
20192—131,896
2020412112,182
20211—272,297
20226101211,749
20236199191,615
2024618811,948
2025725701,923
2026815311—

What is it indicated for?

The LifeStent NT35 Stent System is indicated for use in the palliation of malignant strictures (neoplasms) in the biliary tree

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K042985: Lifestent NT35 Biliary Stent System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K042985

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026